Artykuły udostępnione publicznie: - Amedeo LonardoWięcej informacji
Niedostępne w żadnym miejscu: 3
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
A Lonardo, A Mantovani, S Petta, A Carraro, CD Byrne, G Targher
Nature Reviews Endocrinology 18 (10), 638-650, 2022
Upoważnienia: National Institute for Health Research, UK
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
H Zhang, G Targher, CD Byrne, SU Kim, VWS Wong, L Valenti, ...
Hepatology international 18 (4), 1178-1201, 2024
Upoważnienia: National Institute of Health and Medical Research, France, Government of …
Global, regional, and national burden of primary liver cancer attributable to metabolic risks: an analysis of the Global Burden of Disease Study 1990-2021
C Wu, G Targher, CD Byrne, Y Mao, TT Cheung, Y Yilmaz, L Valenti, ...
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
Upoważnienia: National Natural Science Foundation of China
Dostępne w jakimś miejscu: 22
Sex and gender: modifiers of health, disease, and medicine
F Mauvais-Jarvis, NB Merz, PJ Barnes, RD Brinton, JJ Carrero, ...
The Lancet 396 (10250), 565-582, 2020
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs, Swedish …
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis
G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui
Journal of hepatology 65 (3), 589-600, 2016
Upoważnienia: National Institute for Health Research, UK
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ...
Hepatology 70 (4), 1457-1469, 2019
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs …
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
G Targher, A Lonardo, CD Byrne
Nature reviews endocrinology 14 (2), 99-114, 2018
Upoważnienia: National Institute for Health Research, UK
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis
A Mantovani, G Zaza, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 79, 64-76, 2018
Upoważnienia: National Institute for Health Research, UK
Non-alcoholic fatty liver disease and risk of cardiovascular disease
A Lonardo, S Sookoian, CJ Pirola, G Targher
Metabolism 65 (8), 1136-1150, 2016
Upoważnienia: Government of Argentina
Liver and diabetes. A vicious circle
P Loria, A Lonardo, F Anania
Hepatology research 43 (1), 51-64, 2013
Upoważnienia: US National Institutes of Health
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
A Mantovani, G Petracca, G Beatrice, A Csermely, A Lonardo, ...
Gut 71 (1), 156-162, 2022
Upoważnienia: National Institute for Health Research, UK
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms
LE Adinolfi, R Zampino, L Restivo, A Lonardo, B Guerrera, A Marrone, ...
World journal of gastroenterology: WJG 20 (13), 3410, 2014
Upoważnienia: Government of Italy
Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis
A Mantovani, M Dauriz, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 87, 1-12, 2018
Upoważnienia: National Institute for Health Research, UK
Perspectives on precision medicine approaches to NAFLD diagnosis and management
A Lonardo, JP Arab, M Arrese
Advances in Therapy 38 (5), 2130-2158, 2021
Upoważnienia: European Commission
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis
A Mantovani, T Turino, A Altomari, A Lonardo, G Zoppini, L Valenti, H Tilg, ...
Metabolism 96, 56-65, 2019
Upoważnienia: National Institute for Health Research, UK
Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name
SA Polyzos, ES Kang, EA Tsochatzis, S Kechagias, M Ekstedt, ...
Metabolism-Clinical and Experimental 113, 2020
Upoważnienia: State of Califonia
Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies
S Ballestri, A Mantovani, C Byrne, A Lonardo, G Targher
Metabolism and Target Organ Damage 1 (7), 2021
Upoważnienia: National Institute for Health Research, UK
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
A Lonardo, AK Singal, N Osna, KK Kharbanda
Metabolism and target organ damage 2 (3), 12, 2022
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Association between non-alcoholic fatty liver disease and decreased lung function in adults: a systematic review and meta-analysis
A Mantovani, A Lonardo, G Vinco, G Zoppini, G Lippi, E Bonora, ...
Diabetes & metabolism 45 (6), 536-544, 2019
Upoważnienia: National Institute for Health Research, UK
Nonalcoholic fatty liver disease is associated with higher 1-year all-cause rehospitalization rates in patients admitted for acute heart failure
F Valbusa, S Bonapace, C Grillo, L Scala, A Chiampan, A Rossi, ...
Medicine 95 (7), e2760, 2016
Upoważnienia: National Institute for Health Research, UK
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy